Teresita M Bellido

University Of Arkansas Med Scis Ltl Rock

$8,482,287

Attributed

$10,261,539

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $763K · FY2005–25

$1M$750K$500K$250K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$10,261,539 · 9

VA$0 · 3

By mechanism

R01$8,196,929 · 3

P01$1,229,662 · 1

K02$382,693 · 1

R29$219,822 · 1

R13$131,000 · 2

R03$101,433 · 1

Top collaborators

Others in their field

Top investigators on “Osteocytes”

Brendan Hl Lee · Baylor College Of Medicine$12,111,241
Mitchell B Schaffler · Mount Sinai School Of Medicine Of Nyu$10,776,075
Sarah L Dallas · University Of Missouri Kansas City$10,095,218
Sundeep Khosla · Mayo Clinic Rochester$9,612,446
Charles A O'Brien · Univ Of Arkansas For Med Scis$9,260,858
Nicolae Valentin David · Northwestern University$8,342,353

Research focus

OsteocytesCellsSignal TransductionOsteoblastsPreventApoptosisBoneMediatingIn VivoBaseOsteogenesisResponseGeneticIn VitroExhibitsMechanicsSkeletonGlucocorticoidsBone RemodelingSkeletalGenesBone StrengthOsteoporosisTnfsf11 Gene

Grant awards (67)

Contribution of osteocytes to the musculoskeletal effects of Multiple Myeloma$454,799

R01 · FY2025 · CA

BLRD Research Career Scientist Award Application$0

IK6 · FY2025 · VA · contact PI

BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB)$0

I01 · FY2025 · VA · contact PI

Contribution of osteocytes to the musculoskeletal effects of Multiple Myeloma$432,059

R01 · FY2024 · CA

ASBMR Three Year Pre-Meeting Symposia$35,000

R13 · FY2024 · AR · contact PI

Eighteenth Forum on Osteoporosis and Metabolic Bone Diseases for Fellows in Training$18,000

R13 · FY2024 · AR

BLRD Research Career Scientist Award Application$0

IK6 · FY2024 · VA · contact PI

Contribution of osteocytes to the musculoskeletal effects of Multiple Myeloma$449,805

R01 · FY2023 · CA

ASBMR Three Year Pre-Meeting Symposia$35,000

R13 · FY2023 · AR · contact PI

PTH receptor Signaling and Diabetes-induced Bone Disease$0

I01 · FY2023 · VA · contact PI

BLR&D Research Career Scientist Award Application for Teresita Bellido, PhD$0

IK6 · FY2023 · VA · contact PI

Glucocorticoid-induced Atrophy in Bone and Muscle$331,057

R01 · FY2022 · AR · contact PI

ASBMR Three Year Pre-Meeting Symposia$43,000

R13 · FY2022 · AR · contact PI

PTH receptor Signaling and Diabetes-induced Bone Disease$0

I01 · FY2022 · VA · contact PI

BLR&D Research Career Scientist Award Application for Teresita Bellido, PhD$0

IK6 · FY2022 · VA · contact PI

Contribution of Osteocytes to the Musculoskeletal Effects of Multiple Myeloma$409,850

R01 · FY2021 · CA · contact PI

Glucocorticoid-induced Atrophy in Bone and Muscle$324,368

R01 · FY2021 · AR · contact PI

BLR&D Research Career Scientist Award Application for Teresita Bellido, PhD$0

IK6 · FY2021 · VA · contact PI

PTH receptor Signaling and Diabetes-induced Bone Disease$0

I01 · FY2021 · VA · contact PI

Contribution of Osteocytes to the Musculoskeletal Effects of Multiple Myeloma$349,622

R01 · FY2020 · CA · contact PI

Glucocorticoid-induced Atrophy in Bone and Muscle$225,921

R01 · FY2020 · AR · contact PI

Glucocorticoid-induced Atrophy in Bone and Muscle$112,405

R01 · FY2020 · AR · contact PI

Contribution of Osteocytes to the Musculoskeletal Effects of Multiple Myeloma$75,058

R01 · FY2020 · CA · contact PI

BLR&D Research Career Scientist Award Application for Teresita Bellido, PhD$0

IK6 · FY2020 · VA · contact PI

PTH receptor Signaling and Diabetes-induced Bone Disease$0

I01 · FY2020 · VA · contact PI

BLR&D Research Career Scientist Award Application for Teresita Bellido, PhD$0

IK6 · FY2020 · VA · contact PI

PTH receptor Signaling and Diabetes-induced Bone Disease$0

I01 · FY2020 · VA · contact PI

Contribution of Osteocytes to the Musculoskeletal Effects of Multiple Myeloma$411,939

R01 · FY2019 · CA

Glucocorticoid-induced Atrophy in Bone and Muscle$346,500

R01 · FY2019 · AR · contact PI

BLR&D Research Career Scientist Award Application for Teresita Bellido, PhD$0

IK6 · FY2019 · VA · contact PI

PTH receptor Signaling and Diabetes-induced Bone Disease$0

I01 · FY2019 · VA · contact PI

Contribution of Osteocytes to the Musculoskeletal Effects of Multiple Myeloma$403,994

R01 · FY2018 · CA

Glucocorticoid-induced Atrophy in Bone and Muscle$346,500

R01 · FY2018 · AR · contact PI

PTH receptor Signaling and Diabetes-induced Bone Disease$0

I01 · FY2018 · VA · contact PI

Contribution of Osteocytes to the Musculoskeletal Effects of Multiple Myeloma$402,712

R01 · FY2017 · CA

Osteocyte control of bone remodeling through the PTH receptor$0

I01 · FY2017 · VA · contact PI

Osteocyte control of bone remodeling through the PTH receptor$0

I01 · FY2016 · VA · contact PI

FAK/Pyk2 signaling pathway and bone formation$346,500

R01 · FY2015 · AR · contact PI

Osteocyte control of bone remodeling through the PTH receptor$0

I01 · FY2015 · VA · contact PI

FAK/Pyk2 signaling pathway and bone formation$339,570

R01 · FY2014 · AR · contact PI

Osteocyte control of bone remodeling through the PTH receptor$0

I01 · FY2014 · VA · contact PI

FAK/Pyk2 signaling pathway and bone formation$329,175

R01 · FY2013 · AR · contact PI

FAK/Pyk2 signaling pathway and bone formation$346,500

R01 · FY2012 · AR · contact PI

FAK/Pyk2 signaling pathway and bone formation$346,500

R01 · FY2011 · AR · contact PI

Osteocyte control of bone formation via Sost$341,295

R01 · FY2010 · DK · contact PI

MECHANICAL FORCES, OSTEOCYTES VAIBILITY, AND BONE STRENGTH IN OLD AGE$280,726

P01 · FY2010 · AG · contact PI

Osteocyte control of bone formation via Sost$76,670

R01 · FY2010 · DK · contact PI

Osteocyte control of bone formation via Sost$343,714

R01 · FY2009 · DK · contact PI

MECHANICAL FORCES, OSTEOCYTES VAIBILITY, AND BONE STRENGTH IN OLD AGE$275,382

P01 · FY2009 · AG · contact PI

Osteocyte control of bone formation via Sost$343,043

R01 · FY2008 · DK · contact PI

MECHANICAL FORCES, OSTEOCYTES VAIBILITY, AND BONE STRENGTH IN OLD AGE$270,929

P01 · FY2008 · AG · contact PI

Osteocyte control of bone formation via Sost$307,373

R01 · FY2007 · DK · contact PI

MECHANICAL FORCES, OSTEOCYTES VAIBILITY, AND BONE STRENGTH IN OLD AGE$236,263

P01 · FY2007 · AG · contact PI

Bisphosphonate binding to connexin43-expressing cells$19,356

R03 · FY2007 · TW · contact PI

Bisphosphonate binding to connexin43-expressing cells$11,726

R03 · FY2007 · TW · contact PI

MECHANICAL FORCES, OSTEOCYTES VAIBILITY, BONE STRENGTH$166,362

P01 · FY2006 · AG · contact PI

Bisphosphonate binding to connexin43-expressing cells$31,851

R03 · FY2006 · TW · contact PI

Bisphosphonate binding to connexin43-expressing cells$38,500

R03 · FY2005 · TW

CYTOKINE SIGNAL TRANSDUCTION IN OSTEOBLASTIC CELLS$81,129

K02 · FY2004 · AR

CYTOKINE SIGNAL TRANSDUCTION IN OSTEOBLASTIC CELLS$78,765

K02 · FY2003 · AR

CYTOKINE SIGNAL TRANSDUCTION IN OSTEOBLASTIC CELLS$76,472

K02 · FY2002 · AR

SIGNALS CONTROLLING OSTEOCYTE VIABILITY$0

P01 · FY2002 · AG

CYTOKINE SIGNAL TRANSDUCTION IN OSTEOBLASTIC CELLS$112,502

R29 · FY2001 · AR

CYTOKINE SIGNAL TRANSDUCTION IN OSTEOBLASTIC CELLS$74,245

K02 · FY2001 · AR

SIGNALS CONTROLLING OSTEOCYTE VIABILITY$0

P01 · FY2001 · AG

CYTOKINE SIGNAL TRANSDUCTION IN OSTEOBLASTIC CELLS$107,320

R29 · FY2000 · AR

CYTOKINE SIGNAL TRANSDUCTION IN OSTEOBLASTIC CELLS$72,082

K02 · FY2000 · AR